These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36016606)

  • 1. Exploring the pharmacological mechanism of compound kushen injection in the treatment of breast cancer using
    Ye Y; Zhang B; Liang Q; Wang D; Bai F; Li Y; Wei L; Li L; Huang H; Tang Y
    Front Oncol; 2022; 12():946758. PubMed ID: 36016606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification.
    Liu S; Hu X; Fan X; Jin R; Yang W; Geng Y; Wu J
    Evid Based Complement Alternat Med; 2020; 2020():2758640. PubMed ID: 32849897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
    Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
    Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
    Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
    J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
    He R; Ou S; Chen S; Ding S
    Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
    Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
    World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics.
    Qu Z; Cui J; Harata-Lee Y; Aung TN; Feng Q; Raison JM; Kortschak RD; Adelson DL
    Oncotarget; 2016 Oct; 7(40):66003-66019. PubMed ID: 27602759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer.
    Li Y; Wang K; Chen Y; Cai J; Qin X; Lu A; Guan D; Qin G; Chen W
    Front Pharmacol; 2021; 12():723147. PubMed ID: 34899291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.
    Wu C; Huang ZH; Meng ZQ; Fan XT; Lu S; Tan YY; You LM; Huang JQ; Stalin A; Ye PZ; Wu ZS; Zhang JY; Liu XK; Zhou W; Zhang XM; Wu JR
    Chin Med; 2021 Nov; 16(1):121. PubMed ID: 34809653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Advanced Systems Pharmacology Strategy Reveals
    Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
    Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
    Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
    BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology in combination with bibliometrics analysis on the mechanism of compound Kushen injection in the treatment of radiation pneumonia and lung cancer.
    Lv M; Feng Y; Zeng S; Zhang Y; Shen W; Guan W; E X; Zeng H; Zhao R; Yu J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Dec; 397(12):9789-9809. PubMed ID: 38918234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
    Liang S; Li Y; Zhang X; Guo Y; Pan S
    Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
    Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
    J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway.
    Huang Z; Wu C; Zhou W; Lu S; Tan Y; Wu Z; You R; Stalin A; Guo F; Zhang J; Liu P; Wang W; Duan X; You L; Wu J
    Phytomedicine; 2023 Sep; 118():154984. PubMed ID: 37487253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A UPLC-Q-TOF/MS-based plasma metabolomics approach reveals the mechanism of Compound Kushen Injection-based intervention against non-small cell lung cancer in Lewis tumor-bearing mice.
    Wu H; Wang L; Zhan X; Wang B; Wu J; Zhou A
    Phytomedicine; 2020 Jun; 76():153259. PubMed ID: 32534358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening and network pharmacology-based synergistic coagulation mechanism identification of multiple components contained in compound Kushen Injection against hepatocellular carcinoma.
    Zhou K; Xie M; Liu Y; Zheng L; Pu J; Wang C
    J Ayurveda Integr Med; 2024; 15(5):101055. PubMed ID: 39427483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.
    Xu W; Lin H; Zhang Y; Chen X; Hua B; Hou W; Qi X; Pei Y; Zhu X; Zhao Z; Yang L
    J Exp Clin Cancer Res; 2011 Oct; 30(1):103. PubMed ID: 22032476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics.
    Zhang Y; Xu L; Li L
    Medicine (Baltimore); 2023 Sep; 102(36):e35135. PubMed ID: 37682145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.